Reata Pharmaceuticals Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

25,836

Value ($000)

2,349

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	2,349	0.0%	25,836	6/30/2023
2023 Q1	5/15/2023	2,349	0.0%	25,836	3/31/2023
2022 Q4	2/14/2023	904	0.0%	23,808	12/31/2022
2022 Q3	11/14/2022	560	0.0%	22,268	9/30/2022
2022 Q2	8/12/2022	985	0.0%	32,427	6/30/2022
2022 Q1	5/16/2022	940	0.0%	28,685	3/31/2022
2021 Q4	2/14/2022	687	0.0%	26,042	12/31/2021
2021 Q3	11/15/2021	3,129	0.0%	31,105	9/30/2021
2021 Q2	8/16/2021	4,522	0.0%	31,954	6/30/2021
2021 Q1	5/14/2021	3,791	0.0%	38,028	3/31/2021
2020 Q4	3/1/2021	4,747	0.0%	38,400	12/31/2020
2020 Q3	11/13/2020	3,196	0.0%	32,803	9/30/2020
2020 Q2	8/14/2020	4,987	0.0%	31,964	6/30/2020
2020 Q1	5/15/2020	3,390	0.0%	23,487	3/31/2020
2019 Q4	2/14/2020	4,494	0.0%	21,985	12/31/2019